Which statement best describes the primary mechanism by which aspirin provides benefit in suspected myocardial infarction?

Which statement best describes the primary mechanism by which aspirin provides benefit in suspected myocardial infarction?

• A. It dissolves clots immediately.
• B. It inhibits platelet aggregation to prevent further clot formation.
• C. It lowers blood pressure.
• D. It increases red blood cell production.

Answer: (B)

Aspirin helps in suspected myocardial infarction mainly by preventing the clot from growing, not by dissolving it. It achieves this by irreversibly inhibiting the enzyme COX-1 in platelets, which lowers the production of thromboxane A2, a chemical that promotes platelet aggregation and vasoconstriction. Because platelets have no nucleus, they can’t synthesize new COX-1, so the antiplatelet effect lasts for the life of the platelet (about 7–10 days). By reducing platelet clumping, aspirin decreases the chance of a larger or further clot forming, which can improve survival when given early. It doesn’t dissolve an existing clot—that’s what thrombolytics do. It also doesn’t lower blood pressure or increase red blood cell production, which are not effects of aspirin. In practice, a chewable 160–325 mg dose is common to maximize rapid absorption.

Aspirin helps in suspected myocardial infarction mainly by preventing the clot from growing, not by dissolving it. It achieves this by irreversibly inhibiting the enzyme COX-1 in platelets, which lowers the production of thromboxane A2, a chemical that promotes platelet aggregation and vasoconstriction. Because platelets have no nucleus, they can’t synthesize new COX-1, so the antiplatelet effect lasts for the life of the platelet (about 7–10 days). By reducing platelet clumping, aspirin decreases the chance of a larger or further clot forming, which can improve survival when given early.

It doesn’t dissolve an existing clot—that’s what thrombolytics do. It also doesn’t lower blood pressure or increase red blood cell production, which are not effects of aspirin. In practice, a chewable 160–325 mg dose is common to maximize rapid absorption.